Harrow (HROW) Earnings Date & Reports

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

HROW is expected to report earnings to fall 85.14% to -10 cents per share on August 11

Q2'26

Est.

$-0.11

Q1'26

Missed

by $0.39

Q4'25

Missed

by $0.22

Q3'25

Beat

by $0.09

Q2'25

Beat

by $0.23

The last earnings report on May 11 showed earnings per share of -74 cents, missing the estimate of -34 cents. With 529.53K shares outstanding, the current market capitalization sits at 1.55B.

View a ticker or compare two or three

Compare

HROW

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HROW